A pilot test for implementing precision healthcare programme in patients with diabetes in Indonesia

Q4 Medicine

Scripta Medica Pub Date : 2023-01-01 DOI:10.5937/scriptamed54-42230

Satriya Pranata, S. Wu, Tsae‐Jyy Wang, S. Liang, Bistara Nobel, Y. Chuang, K. Lu, Atmaja Kusuma

{"title":"A pilot test for implementing precision healthcare programme in patients with diabetes in Indonesia","authors":"Satriya Pranata, S. Wu, Tsae‐Jyy Wang, S. Liang, Bistara Nobel, Y. Chuang, K. Lu, Atmaja Kusuma","doi":"10.5937/scriptamed54-42230","DOIUrl":null,"url":null,"abstract":"Background/Aim: An evaluation of precision healthcare interventions among patients with diabetes in a small sample through a pilot test before being tested in a larger sample is needed. Thus, the purpose of this study was to evaluate the feasibility of a precision healthcare programme. It also assesses the programme's outcome among patients with diabetes in Indonesia. Methods: Data were collected during December 2020. The researchers first gathered data about participant characteristics. Furthermore, the strategies of precision healthcare were implemented in sixty respondents to evaluate the feasibility and outcome of the programme in a month. Results: The participants mentioned that they can follow all procedures of precision healthcare. However, they asked the researcher to provide a guide and monitoring book which provides safe choices information on diet, exercise, glucose monitoring and drug medication. Moreover, participants mentioned that they could complete all questionnaires but needed a company of a research assistant. The benefits of a month of precision healthcare were improved diabetes self-care activity, blood pressure and blood glucose level. However, the body weight, body mass index (BMI), triglyceride, cholesterol and triglyceride glucose index were not significantly improved. Conclusion: A pilot test is needed to ensure the feasibility of the implementation strategy with the culture and background of diabetic patients in Indonesia. Improving diabetes self-care activity stabilised blood pressure and blood glucose during a month, so it can be assumed that precision healthcare approaches were potentially being applied in Indonesia. On the other hand, it is needed more than a month to improve body weight, BMI, triglyceride, cholesterol and triglyceride glucose index. Thus, testing the precision healthcare approach in a larger sample with long time series for patients with diabetes in Indonesia through a randomised controlled trial (RCT) is needed.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scripta Medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/scriptamed54-42230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

Background/Aim: An evaluation of precision healthcare interventions among patients with diabetes in a small sample through a pilot test before being tested in a larger sample is needed. Thus, the purpose of this study was to evaluate the feasibility of a precision healthcare programme. It also assesses the programme's outcome among patients with diabetes in Indonesia. Methods: Data were collected during December 2020. The researchers first gathered data about participant characteristics. Furthermore, the strategies of precision healthcare were implemented in sixty respondents to evaluate the feasibility and outcome of the programme in a month. Results: The participants mentioned that they can follow all procedures of precision healthcare. However, they asked the researcher to provide a guide and monitoring book which provides safe choices information on diet, exercise, glucose monitoring and drug medication. Moreover, participants mentioned that they could complete all questionnaires but needed a company of a research assistant. The benefits of a month of precision healthcare were improved diabetes self-care activity, blood pressure and blood glucose level. However, the body weight, body mass index (BMI), triglyceride, cholesterol and triglyceride glucose index were not significantly improved. Conclusion: A pilot test is needed to ensure the feasibility of the implementation strategy with the culture and background of diabetic patients in Indonesia. Improving diabetes self-care activity stabilised blood pressure and blood glucose during a month, so it can be assumed that precision healthcare approaches were potentially being applied in Indonesia. On the other hand, it is needed more than a month to improve body weight, BMI, triglyceride, cholesterol and triglyceride glucose index. Thus, testing the precision healthcare approach in a larger sample with long time series for patients with diabetes in Indonesia through a randomised controlled trial (RCT) is needed.

查看原文本刊更多论文

在印度尼西亚对糖尿病患者实施精准保健方案的试点试验

背景/目的:在更大的样本中进行测试之前，需要在小样本中通过试点测试来评估糖尿病患者的精确医疗保健干预措施。因此，本研究的目的是评估精准医疗方案的可行性。它还评估了该方案在印度尼西亚糖尿病患者中的效果。方法:于2020年12月收集数据。研究人员首先收集了有关参与者特征的数据。此外，在60名受访者中实施了精准医疗保健战略，以在一个月内评估该方案的可行性和结果。结果:参试者均表示能够遵循精准医疗的所有流程。然而，他们要求研究人员提供一份指南和监测书，提供有关饮食、运动、血糖监测和药物治疗的安全选择信息。此外，参与者提到他们可以完成所有问卷，但需要一个研究助理的陪伴。一个月的精准医疗的好处是改善糖尿病自我护理活动，血压和血糖水平。然而，体重、体重指数(BMI)、甘油三酯、胆固醇和甘油三酯葡萄糖指数没有明显改善。结论:根据印尼糖尿病患者的文化和背景，需要进行中试，以确保实施策略的可行性。改善糖尿病自我护理活动在一个月内稳定了血压和血糖，因此可以假设精确医疗保健方法可能在印度尼西亚得到应用。另一方面，改善体重、BMI、甘油三酯、胆固醇和甘油三酯葡萄糖指数需要一个多月的时间。因此，需要通过随机对照试验(RCT)在印度尼西亚糖尿病患者的更大样本和长时间序列中测试精确医疗保健方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Scripta Medica

CiteScore

0.60

自引率

0.00%

发文量

审稿时长

4 weeks